#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypotransferrinaemia Niemann-Pick disease Antiphospholipid syndrome Antisynthetase syndrome Transplant rejection Mucopolysaccharidosis II Fibrodysplasia ossificans progressiva Deafness neurosensory Dementia Alzheimer's type Piriformis syndrome Acute myeloid leukaemia (in remission) Retinal artery occlusion Factor IX deficiency Thalassaemia beta Mantle cell lymphoma stage II More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune Adrenogenital syndrome – Trials in Disease Hereditary optic atrophy – Diagnostics Breast angiosarcoma metastatic – Basic Information Erdheim-Chester disease – Life with Disease Inclusion body myositis – Diagnostics Mantle cell lymphoma refractory Hyperoxaluria – Basic Information Marginal zone lymphoma refractory – Treatment Rhabdoid tumour – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apadamtase Alfa Bms-986315 Buloxibutid Hydrocortisone Hemisuccinate Phenylbutyrate Keto-Isoleucine Calcium KETOROLAC Nomegestrol Acetate Methylphenidate Hydrochloride SIGVOTATUG VEDOTIN Clopidogrel Remifentanil Setanaxib Tipapkinogene Sovacivec His203-Crm197 Glipizide Metamizole Sodium Monohydrate Dirocaftor Aceclofenac Venlafaxine Hydrochloride More therapies…

    Learn about Your Condition

    Osteoarthritis Rhabdomyosarcoma recurrent Hereditary ataxia Intestinal ischaemia B-cell type acute leukaemia Diffuse large B-cell lymphoma Gastrointestinal melanoma Laparotomy Foot deformity Post procedural oedema Peripheral artery stenosis Status epilepticus Acromegaly Dilated cardiomyopathy Atrial septal defect More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Behavior and Behavior Mechanisms

  • Study of semaglutide to reduce cannabis use in adults with cannabis use disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Semaglutide
    • Sodium Chloride
    Denmark

  • A study testing semaglutide with counselling to reduce cravings and use of chemsex-related drugs in adults who use these substances

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Semaglutide
    Belgium

  • Study on Improving Social Interaction in Children with Autism Using Oxytocin Nasal Spray and Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on Oxytocin’s Effects on Trust and Learning in Healthy Children Using Nasal Spray

    Recruiting

    1 1 1
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Title: Evaluation of lorazepam, pregabalin, and olanzapine in treating agitated behavior in dementia patients who did not respond to standard treatments

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia
    Investigated Drugs:
    • Pregabalin
    • Lorazepam
    • Fluoxetine Hydrochloride
    The Netherlands

  • Study on the Safety and Effectiveness of Dexamfetamine Sulfate for Adults with ADHD and Moderate to Severe Depression

    Recruiting

    2 1 1
    Investigated Drugs:
    • Dexamfetamine Sulfate
    Germany
1 2 3 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!